SCHEMBL6979874

SCHEMBL6979874

O=C(O)c1ccc(CCCCCSc2nc(-c3ccc(N4CCOCC4)cc3)cc(=O)[nH]2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.47
HDAC1 Q13547 4/20 0.47
HDAC6 Q9UBN7 4/20 0.47
HDAC3 O15379 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
GPR84 Q9NQS5 3/20 0.39
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
HTT P42858 1/20 0.38
ACMSD Q8TDX5 1/20 0.37
MAPK1 P28482 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981656 0.92 XDH (0.44) XDHHDAC1HDAC6HDAC3HDAC2
SCHEMBL6979872 0.86 GPR84 (0.42) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6982543 0.86 HDAC1 (0.62) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6978480 0.86 HDAC1 (0.59) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6980578 0.82 HDAC1 (0.53) XDHHDAC1HDAC6HDAC3HDAC2
SCHEMBL6977299 0.82 HDAC1 (0.57) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6983466 0.79 HSD17B10 (0.40) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6978096 0.79 HDAC1 (0.60) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6978040 0.78 HDAC1 (0.57) HDAC1HDAC6HDAC3HDAC2HDAC10
SCHEMBL6973306 0.76 HDAC1 (0.52) XDHHDAC1HDAC6HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed